已收盘 09-19 16:00:00 美东时间
-0.270
-0.99%
Johnson & Johnson and Protagonist Therapeutics announced new data from their Phase 3 studies to treat severe plaque psoriasis.
09-18 03:15
Johnson & Johnson (NYSE:JNJ) said that data from late-stage studies showed that its oral medication, icotrokinra, was more effective compared with Bristol Myers' (BMY) deucravacitinib (Sotyktu) for mo...
09-17 21:44
Amgen and Kyowa Kirin report positive interim results for rocatinlimab, showing long-term safety and sustained efficacy in moderate to severe atopic dermatitis patients.
09-10 03:06
Amgen (NASDAQ:AMGN) and Kyowa Kirin (OTCPK:KYKOF) announced on Tuesday that their antibody therapy rocatinlimab is safe and effective in the long term, based on data from a Phase 3 trial for patients ...
09-09 19:08
Each startup to receive up to $500,000 in investment and future research opport...
07-17 03:58
Allspring's three new actively managed ETFs offer exposure to quality stocks and ultra-short municipal bonds with tax-free income potential.
07-09 03:39
ALRG, ASCE, and AUSM join growing suite of ETFs, all based on proven strategies CHARLOTTE, N.C., July 8, 2025 /PRNewswire/ -- Allspring Global Investments™, a global asset management firm wi...
07-08 20:31